Pages that link to "Q92094304"
Jump to navigation
Jump to search
The following pages link to Elaine Peskind (Q92094304):
Displaying 50 items.
- SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease (Q21144971) (← links)
- S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10 (Q21562503) (← links)
- Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues (Q24291384) (← links)
- The ageing systemic milieu negatively regulates neurogenesis and cognitive function. (Q24599219) (← links)
- Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association (Q24683646) (← links)
- Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation. (Q27311994) (← links)
- Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease (Q27314618) (← links)
- Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease. (Q27322563) (← links)
- Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease (Q27333599) (← links)
- Rarity of the Alzheimer disease-protective APP A673T variant in the United States (Q27346292) (← links)
- Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease (Q28373091) (← links)
- Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease (Q28743561) (← links)
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease (Q28943325) (← links)
- GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease (Q29417137) (← links)
- Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease (Q29614374) (← links)
- Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. (Q30428012) (← links)
- Validation of consensus panel diagnosis in dementia (Q30429412) (← links)
- The role of norepinephrine in differential response to stress in an animal model of posttraumatic stress disorder (Q30450972) (← links)
- Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study (Q30459046) (← links)
- Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study (Q30481797) (← links)
- Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. (Q30489052) (← links)
- DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease (Q30493811) (← links)
- Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. (Q30496676) (← links)
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression (Q30501271) (← links)
- Phosphorylated α-synuclein in Parkinson's disease (Q30510167) (← links)
- Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and Alzheimer's disease: evidence for γ-secretase dysfunction (Q30511181) (← links)
- DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease (Q30529658) (← links)
- Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span (Q30580439) (← links)
- Targeted discovery and validation of plasma biomarkers of Parkinson's disease (Q30597182) (← links)
- Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease (Q30659251) (← links)
- The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers (Q31081008) (← links)
- Plasma catecholamine and cardiovascular responses to physostigmine in Alzheimer's disease and aging (Q31593107) (← links)
- Human glucocorticoid feedback inhibition is reduced in older individuals: evening study (Q31831162) (← links)
- Characterization of proteome of human cerebrospinal fluid (Q33245302) (← links)
- Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. (Q33254291) (← links)
- Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform (Q33314117) (← links)
- Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects (Q33438465) (← links)
- The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery (Q33454243) (← links)
- Glycoproteomics in neurodegenerative diseases (Q33563387) (← links)
- Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism (Q33665842) (← links)
- Safety of lumbar puncture procedures in patients with Alzheimer's disease. (Q33671485) (← links)
- Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients (Q33715239) (← links)
- Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. (Q33740938) (← links)
- Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults (Q33868184) (← links)
- Blast exposure causes early and persistent aberrant phospho- and cleaved-tau expression in a murine model of mild blast-induced traumatic brain injury (Q34020032) (← links)
- Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers (Q34146458) (← links)
- Influence of lifestyle modifications on age-related free radical injury to brain (Q34160762) (← links)
- Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study (Q34174352) (← links)
- Alzheimer's disease and related disorders (Q34249305) (← links)
- CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment. (Q34299993) (← links)